Erythropoietin ELISA (EPO ELISA)

$555.00
Catalog
21-EPOHU-E01
The Erythropoietin ELISA (EPO ELISA) is a specific quantitative assay for the determination of erythropoietin in Serum. Human EPO is a heavily glycosylated protein consisting of 165 amino acids. Serum EPO levels are dependent on the rate of production and the rate of clearance of the protein. Quantitation of serum erythropoietin is useful in researching the cause of anemia or erythrocytosis. FDA Registered. For In Vitro Diagnostic Use.
Species
Human
Regulatory Status
FDA Registered. For In Vitro Diagnostic Use.
Product Distribution
Available Worldwide
Range
3 - 500 mIU/mL
Sensitivity
0.6 mIU/mL
Sizes
96 Wells
Sample Types
Serum
Inc Time Hour
2
Inc Time Minute
30
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
400
Detection
Colorimetric
The EPO Immunoassay is a two-site ELISA [enzyme-linked immunosorbent assay] for themeasurement of the biologically active 165 amino acid chain of EPO. It utilizes two differentmouse monoclonal antibodies to human EPO specific for well-defined regions on the EPOmolecule. One mouse monoclonal antibody to human EPO is biotinylated and the other mousemonoclonal antibody to human EPO is labeled with horseradish peroxidase [HRP] for detection. In this assay, calibrators, controls, or patient samples are simultaneously incubated with the enzyme-labeled antibody and a biotin-coupled antibody in a streptavidin-coated microplate well. At the endof the assay incubation, the microwell is washed to remove unbound components and the enzymebound to the solid phase is incubated with the substrate, tetramethylbenzidine (TMB). An acidicstop solution is then added to stop the reaction and converts the color to yellow. The intensity of the yellow color is directly proportional to the concentration of EPO in the sample. A dose-responsecurve of absorbance units versus concentration is generated using results obtained from thecalibrators. Concentrations of EPO present in the controls and patient samples are determineddirectly from this curve. The standards have been calibrated against the World Health Organization(WHO) erythropoietin international standard that consists of recombinant DNA derived EPO. TheWHO reference standard used was the erythropoietin 1st international standard (87/684).

Erythropoietin ELISA (EPO ELISA)

21-EPOHU-E01

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

Targeted Solutions for Gastroenterology
Targeted Solutions for Gastroenterology
ALPCO offers targeted GI solutions suitable for all types of labs. Our offerings range from plate-based to clinical chemistry analyzer-based and automated flash chemiluminescence solutions, all designed to accommodate your lab’s expanding testing needs and capabilities.
View Now
 Optimizing IBD Management with Fecal Calprotectin: From Diagnosis to Monitoring
Live Webinar: Optimizing IBD Management with Fecal Calprotectin - From Diagnosis to Monitoring
In the webinar, Dr. Benjamin Click from the University of Colorado, Department of Gastroenterology, underscores the critical role of non-invasive monitoring methods, particularly fecal calprotectin monitoring, in guiding treatment adjustments and achieving therapeutic goals..
View Now
GLP-1 Amide Elisa
Product Data: Active GLP-1 (7-36) amide Chemiluminescence ELISA
ALPCO’s Active GLP-1 (7-36) amide Chemiluminescence ELISA accurately measures the major biologically active circulating form of GLP-1.1,2 This well-characterized assay provides high analytical sensitivity, a short incubation time, and measures active GLP-1 (7-36) amide in fasted and fed samples.
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.